跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Renowind - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Renowind
Approved
STANDARD
Renowind
Sapphire Lifesciences Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5932081d4e059636
Company
Sapphire Lifesciences Pvt. Ltd
Type
Standard
Approval Details
Approval Id
5932081d4e059636
Drug Approval Philippines Name
Renowind
Product Name
Renowind
Registration Number
DRP-10830-03
Brand Name
Renowind
Generic Name
Ketoanalogues + Essential Amino Acids
Dosage Form
Film-Coated Tablet
Manufacturer
Sapphire Lifesciences Pvt. Ltd
Importer
Nelpa Lifesciences, Inc.
Distributor
Healthwinds Medical Trading Corp
Issuance Date
26 September 2023
Expiry Date
03 December 2026
Pharmacologic Category
Renal Nutrition Therapy
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5932081d4e059636
Type
Standard
Back to Philippines FDA Approvals